In a thought-provoking essay by Michael Gazzaniga, the October issue of Scientific American explores the use of drugs for “normal” people to enhance their intelligence.
Any child can tell you that some people are smarter than others. But what is the difference between the brain of a Ph.D. student and the brain of the average Joe? If we can figure that out, then a bigger question follows: Is it ethical to turn average Joes into geniuses? Evolutionary theory suggests that if we are smart enough to invent technology that can increase our brain capacity, we should be able to use that advantage. It is the next step in the survival of the fittest. As noted psychologist Corneliu Giurgea stated in the 1970s, “Man is not going to wait passively for millions of years before evolution offers him a better brain.”
That said, gnawing concerns persist when it comes to artificially enhancing intelligence. Geneticists and neuroscientists have made great strides in understanding which genes, brain structures and neurochemicals might be altered artificially to increase intelligence. The fear this prospect brings is that a nation of achievers will discard hard work and turn to prescriptions to get ahead.
Enhancing intelligence is not science fiction. Many “smart” drugs are in clinical trials and could be on the market in less than five years. Some medications currently available to patients with memory disorders may also increase intelligence in the healthy population. Likewise, few people would lament the use of such aids to ameliorate the forgetfulness that aging brings. Drugs that counter these deficits would be adopted gratefully by millions of people.
Drugs designed for psychotherapy can also be used to enhance certain regular mental functions. Just as Ritalin can improve the academic performance of hyperactive children, it can do the same for normal children. It is commonly thought to boost SAT scores by more than 100 points, for both the hyperactive and the normal user. Many healthy young people now use it that way for that purpose, and quite frankly, there is no stopping this abuse.
Comments
This post currently has one comment. You can read the comments or leave your own thoughts on our new comments page.
Trackbacks
No trackbacks yet to this post.
Last reviewed: By John M. Grohol, Psy.D. on 7 Oct 2005
Published on PsychCentral.com. All rights reserved.
Grohol, J. (2005). Smarter on Drugs. Psych Central. Retrieved on May 25, 2012, from http://psychcentral.com/blog/archives/2005/10/07/smarter-on-drugs/


Dr. John Grohol is the CEO and founder of Psych Central. He is an author, researcher and expert in mental health online, and has been writing about online behavior, mental health and psychology issues -- as well as the intersection of technology and human behavior -- since 1992. Dr. Grohol sits on the editorial board of the journal Cyberpsychology, Behavior and Social Networking and is a founding board member and treasurer of the Society for Participatory Medicine.